FDA’s Light Touch With Medical Apps May Let Industry Bloom

Law360, New York (April 5, 2013, 5:03 PM EDT) -- The U.S. Food and Drug Administration’s hands-off approach to mobile medical apps is allowing potentially risky diagnostic tools to be sold to consumers without facing regulatory scrutiny, but stronger enforcement in the short term could stifle a promising and fast-growing field of health care technology, experts say.

Thousands of medical apps are available through Apple Inc.’s App Store and Google Inc.’s Google Play, and while most are innocuous — calorie counters, meditation music players and the like —  a sliver of the market is increasingly devoted...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.